Francis_Leier_2011_4

EMD Crop BioScience

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis_Leier_2011_1

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis Leier discusses how EMD’s parent company, Merck, recently sold its crop bioscience business (which includes EMD Crop BioScience) in the U.S.A, Canada and South America to Novozymes.

Francis_Leier_2011_2

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis Leier explains why Novozymes is a good fit for EMD.

Francis_Leier_2011_3

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis Leier tells Seed World what’s in the pipeline for the next few years.

Francis_Leier_2011_4

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis Leier explains the science behind EMD’s patented LCO Promoter technology.

Francis_Leier_2011_5

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis Leier discusses what direction he thinks the seed enhancement sector will take in the next 5-10 years.

Francis_Leier_2011_6

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis Leier explains how seed enhancements can be improved.

Francis_Leier_2011_7

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis Leier discusses the role seed enhancements play in helping to achieve food security.

Francis_Leier_2011_8

Francis Leier, Business Development Manager, EMD Crop BioScience

Francis Leier discusses the distinction between a seed treatment and a seed enhancement.